Time Source Company Announcement
15 Apr 2026 07:13 AM Exercise and Lapse of Equity Incentive Securities
15 Apr 2026 07:12 AM GSK completes acquisition of 35Pharma Inc.
15 Apr 2026 07:05 AM Half-year Financial Report
15 Apr 2026 07:01 AM Director Appointment
15 Apr 2026 07:01 AM First Compulsory Redemption and Timetable
15 Apr 2026 07:01 AM Obsidian Therapeutics reverse merger with Galera
15 Apr 2026 07:00 AM Portfolio News: 2D Photonics subsidiary grant
15 Apr 2026 07:00 AM Heads of Terms signed with Potentially Limited
15 Apr 2026 07:00 AM Notice of Q1 Trading Update
15 Apr 2026 07:00 AM Update on Intention to Move to Main Market
15 Apr 2026 07:00 AM Fundraise of £750,000
15 Apr 2026 07:00 AM Operational Update: Subnet 46 (RESI)
15 Apr 2026 07:00 AM Change to Significant Shareholder Interest
15 Apr 2026 07:00 AM Publication of 2025 Sustainability Report
15 Apr 2026 07:00 AM Unaudited Portfolio Valuation as at 31 March 2026
15 Apr 2026 07:00 AM Q2 2026 Update and CEO Interviewed on Vox Markets
15 Apr 2026 07:00 AM Online Investor Presentation and Q&A Session
15 Apr 2026 07:00 AM Investor Presentation
15 Apr 2026 07:00 AM Presentation at 18th Annual World Cancer Congress
15 Apr 2026 07:00 AM Participation in Water Tower Research Conference
15 Apr 2026 07:00 AM Cross-Trading on the U.S. OTCQX Market
15 Apr 2026 07:00 AM SELP JV PRICES €500 MILLION 3.875% UNSECURED BONDS
15 Apr 2026 07:00 AM MHRA grants CTA for the POLB 001 TOPICAL trial
15 Apr 2026 07:00 AM Third Quarter FY26 FUMA Update
15 Apr 2026 07:00 AM FOURTH COMPULSORY PARTIAL REDEMPTION OF SHARES
15 Apr 2026 07:00 AM Monthly Valuation Update and Factsheet
15 Apr 2026 07:00 AM Notice of Trading Update
15 Apr 2026 07:00 AM EMI Share Option Scheme
15 Apr 2026 07:00 AM Notice of AGM
15 Apr 2026 07:00 AM First Quarter Results Date
15 Apr 2026 07:00 AM Block Admission
15 Apr 2026 07:00 AM Director/PDMR Shareholding
15 Apr 2026 07:00 AM Board Appointment
15 Apr 2026 07:00 AM Directorate Change
15 Apr 2026 07:00 AM EBT Share Purchase
15 Apr 2026 07:00 AM Directorate Changes
15 Apr 2026 07:00 AM Final Results
15 Apr 2026 07:00 AM Preliminary results for the year ended 31 Jan 2026
15 Apr 2026 07:00 AM Final Results 2025
15 Apr 2026 07:00 AM Appointment of Executive Director
15 Apr 2026 07:00 AM Holding(s) in Company
15 Apr 2026 07:00 AM Holding(s) in Company
15 Apr 2026 07:00 AM Director/PDMR Shareholding
15 Apr 2026 07:00 AM Grant and Confirmation of Share Options
15 Apr 2026 07:00 AM Subscription for Shares to raise £2m
15 Apr 2026 07:00 AM Directorate change
15 Apr 2026 07:00 AM TR1 - Notification of Holdings in Company
15 Apr 2026 07:00 AM Update re LBR Offer for Vantage
15 Apr 2026 07:00 AM Transaction in Own Shares
15 Apr 2026 07:00 AM Results for the full year ended 31 December 2025
UK 100

Latest directors dealings